All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Ovid Therapeutics Inc. revenue reports

Ovid Therapeutics Inc. financial reports, Ovid Therapeutics Inc. annual revenue in 2024. When does Ovid Therapeutics Inc. report revenue?
Add to widgets
Added to widgets

Ovid Therapeutics Inc. total revenue, net income and dynamics of changes in US dollar today

Net revenue Ovid Therapeutics Inc. is now 208 382 779 $. Information about net revenue is taken from open sources. The dynamics of Ovid Therapeutics Inc. net revenue grew by 202 679 592 $ compared to the previous report. The dynamics of Ovid Therapeutics Inc. net income went up. The change was 198 036 808 $. The financial report chart on our website displays information by dates from 30/06/2018 to 31/03/2021. Ovid Therapeutics Inc. financial report on the graph shows the dynamics of assets. The value of "net income" Ovid Therapeutics Inc. on the graph is displayed in blue.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 208 382 779 $ - 176 007 307 $ -
31/12/2020 5 703 187 $ - -22 029 501 $ -
30/09/2020 6 914 034 $ - -16 424 789 $ -
30/06/2020 0 $ - -22 551 196 $ -
30/09/2019 0 $ - -16 634 572 $ -
30/06/2019 0 $ - -13 057 267 $ -
31/03/2019 0 $ - -13 800 195 $ -
31/12/2018 0 $ - -12 899 932 $ -
30/09/2018 0 $ - -12 961 783 $ -
30/06/2018 0 $ - -12 935 140 $ -
Show:
to

Ovid Therapeutics Inc. financial report charts

The latest dates of Ovid Therapeutics Inc. financial statements available online: 30/06/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Ovid Therapeutics Inc. is available online for such a date - 31/03/2021. Gross profit Ovid Therapeutics Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Ovid Therapeutics Inc. is 208 382 779 $

Ovid Therapeutics Inc. quarterly report dates

Total revenue Ovid Therapeutics Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Ovid Therapeutics Inc. is 208 382 779 $ Operating income Ovid Therapeutics Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Ovid Therapeutics Inc. is 176 557 316 $ Net income Ovid Therapeutics Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Ovid Therapeutics Inc. is 176 007 307 $

Current assets Ovid Therapeutics Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Ovid Therapeutics Inc. is 236 662 050 $ Total assets Ovid Therapeutics Inc. refers to the total amount of assets owned by a person or entity. Total assets Ovid Therapeutics Inc. is 237 456 030 $ Current cash Ovid Therapeutics Inc. - the sum of all of the cash a company has on the date of report. Current cash Ovid Therapeutics Inc. is 233 051 160 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
208 382 779 $ -54 934 449 $ 6 914 034 $ - - - - - - -
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
- 60 637 636 $ - - - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
208 382 779 $ 5 703 187 $ 6 914 034 $ - - - - - - -
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
176 557 316 $ -21 591 241 $ -16 403 662 $ -23 141 687 $ -16 765 736 $ -13 322 266 $ -13 553 535 $ -13 126 296 $ -13 175 775 $ -13 209 696 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
176 007 307 $ -22 029 501 $ -16 424 789 $ -22 551 196 $ -16 634 572 $ -13 057 267 $ -13 800 195 $ -12 899 932 $ -12 961 783 $ -12 935 140 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
16 248 909 $ -43 753 852 $ 15 875 295 $ 16 032 945 $ 11 597 633 $ 9 117 495 $ 9 337 304 $ 8 621 585 $ 8 544 547 $ 8 116 385 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
31 825 463 $ 27 294 428 $ 23 317 696 $ 23 141 687 $ 16 765 736 $ 13 322 266 $ 13 553 535 $ 13 126 296 $ 13 175 775 $ 13 209 696 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
236 662 050 $ 74 843 201 $ 90 346 834 $ 44 110 604 $ 39 150 495 $ 53 607 138 $ 62 823 510 $ 44 268 147 $ 55 254 234 $ 65 189 276 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
237 456 030 $ 75 925 518 $ 91 599 016 $ 45 355 298 $ 40 694 177 $ 54 908 278 $ 66 655 592 $ 47 649 602 $ 60 393 974 $ 68 612 088 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
233 051 160 $ 72 033 930 $ 86 866 275 $ 41 253 898 $ 37 907 904 $ 47 361 966 $ 54 600 081 $ 36 489 618 $ 30 513 180 $ 22 535 378 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 10 361 016 $ 9 183 817 $ 8 071 552 $ 8 844 457 $ 10 422 905 $ 7 496 228 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 10 647 578 $ 9 470 379 $ 9 409 791 $ 8 844 457 $ 10 422 905 $ 7 496 228 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 26.16 % 17.25 % 14.12 % 18.56 % 17.26 % 10.93 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
221 109 939 $ 43 631 653 $ 63 643 032 $ 30 482 908 $ 30 046 595 $ 45 437 896 $ 57 245 798 $ 38 805 145 $ 49 971 069 $ 61 115 860 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -9 494 272 $ -11 841 609 $ -12 866 387 $ -10 965 610 $ -10 046 039 $ -11 620 419 $

Last revenue report of Ovid Therapeutics Inc. was 31/03/2021. According to last financial report total revenue in Ovid Therapeutics Inc. was 208 382 779 US dollar and changed by 0% since last year. Net income in Ovid Therapeutics Inc. was 176 007 307 $ in last quartal, net income changes to 0%.

Ovid Therapeutics Inc. stocks data

Ovid Therapeutics Inc. financials